secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001493152-25-002950
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack receives ISO 13485:2016 certification for quality management system
------------------------------------------------------------------------------

- Certification awarded by British Standards Institute after Stage I and Stage II assessments.
- Covers design and development of Glucotrack's long-term implantable Continuous Blood Glucose Monitor (CBGM).
- ISO 13485 is the globally recognized standard for medical device QMS, aligned with FDA QMSR and used in the EU.
- CEO Paul Goode calls certification a major step toward delivering high-quality products.
- No financial updates or guidance changes provided in the announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225002950/0001493152-25-002950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225002950/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer